Molnupiravir
-
{
- All
- News
- Videos
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Reduces Hospitalisation, Says Merck Of COVID-19 Drug, Seeks India's Ok
India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce hospitalisations and speed up recovery in mild cases.
-
Five Indian Drugmakers To Jointly Start Trial Of Merck & Co's Covid Drug
Fivegeneric drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in the country.
-
US To Buy 1.7 Million Courses Of Merck's Experimental COVID-19 Pill
The United States on Wednesday announced an agreement with Merck to buy 1.7 million courses of an experimental antiviral pill against Covid-19.
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
Anti-Covid Pill Shouldn't Be Given To Younger Population: Covid Panel Head
Molnupiravir used in treatment of Covid should not be administered to younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of Covid Working Group of National Technical Advisory Group on Immunisation (NTAGI)
-
Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill
Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
-
Reduces Hospitalisation, Says Merck Of COVID-19 Drug, Seeks India's Ok
India's Hetero Labs said on Friday it sought emergency use nod from the local regulator for Merck's COVID-19 drug molnupiravir, after interim data from a late-stage trial showed it helped reduce hospitalisations and speed up recovery in mild cases.
-
Five Indian Drugmakers To Jointly Start Trial Of Merck & Co's Covid Drug
Fivegeneric drugmakers, including Cipla and Dr Reddy's Laboratories, said on Tuesday they would jointly conduct a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in the country.
-
US To Buy 1.7 Million Courses Of Merck's Experimental COVID-19 Pill
The United States on Wednesday announced an agreement with Merck to buy 1.7 million courses of an experimental antiviral pill against Covid-19.
